United States Últimas notícias

MapLight (NASDAQ:MPLT) announced that its Phase 2 autism trial of 161 patients missed its primary efficacy endpoint.

CRH (NYSE:CRH) signed a definitive agreement to purchase competitor Arcosa for $150 per share in cash.

Fervo Energy (NASDAQ:FRVO) reported a first-quarter net loss of $31.8 million while funding multiple utility-scale geothermal facilities.

Galmed Pharmaceuticals (NASDAQ:GLMD) closed its Colospan acquisition, gaining a device tested on 97 patients.

Definium Therapeutics (NASDAQ:DFTX) stated its depression drug trial succeeded, showing a key 8.1-point improvement over a placebo.

AbbVie (NYSE:ABBV) executed an agreement to acquire Apogee Therapeutics (NASDAQ:APGE) for $135.11 per share in cash, totaling approximately $10.9 billion.

Dr. Wolfgang Pinegger, owner and creator of the GloBra ecosystem, has published SHIFT!. The book describes his life as one of relentless reinvention, from shop floors to blockchains, and from a small Austrian village to travelling the world.

The book works as both memoir and guide to navigating change in business and in life.

HawkEye 360 (NYSE:HAWK) achieved record first-quarter 2026 revenue of $49.8 million due to strong global demand.

Merck (NYSE:MRK) announced positive topline results from its Phase 3 study evaluating tulisokibart for active ulcerative colitis.

Ennis (NYSE:EBF) reported a 1.4% increase in first-quarter revenue to $98.6 million for the period ended May 31, 2026.

Petróleo Brasileiro, also known as Petrobas (NYSE:PBR) approved the final investment decision for a $1.2 billion biorefining project to produce renewable fuels.

Baker Hughes (NASDAQ:BKR) is discussing potential commitments with the European Commission to clear its acquisition of Chart Industries (NYSE:GTLS).